Kallikrein 13 Antibody (1G9)

This product is produced by and distributed for Abnova, a company based in Taiwan.

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined. [provided by RefSeq]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publication 1 - 1 of 1.

Publication using H00026085-M01	Applications	Species
Halbert D, Domenyuk V, Spetzler D et al. Aptamers and uses thereof United States Patent Application US 9958448 B2 2018-01-01

Array H00026085-M01

• Kallikrein 13 Antibodies
• Kallikrein 13 Antibody Pair
• Kallikrein 13 ELISA Kit
• Kallikrein 13 Lysate
• Kallikrein 13 Proteins and Enzyme